TABLE 1.
Anti-hAAT and adenovirus neutralizing antibodies for mice represented in Fig. 1A
Strain | Day 56 serum hAAT (ng/ml) | Serum anti-hAAT IgG at 8 wka
|
Adenovirus neutralizing antibody titerb
|
||
---|---|---|---|---|---|
Dilution of 1:1,000 | Dilution of 1:10,000 | 8 wk | 12 wk | ||
C3H | 773, 994, <50 | +++, +++, +++ | +, +, ++ | 16, 64, 16 | 16, 64, 16 |
B6 | 1,440, 2,049, 1,553 | −, +, − | −, −, − | ≤16, 16, 64 | 64, 64, 64 |
Balb/c | <50, <50, <50, <50 | ++, ++, ++, + | +, +, −, − | —, 16, 64, 16 | —, 16, 16, 64 |
Balb/b | 1,113, 1,642, 400, 1,039 | −, −, −, − | −, −, −, − | ≤16, 64, 16, — | 16, 64, 16, — |
Qualitatively reported for each animal in comparison to a standard curve of anti-hAAT monoclonal antibody (MAb) as follows: −, not detected; +, detected at level similar to that of standard MAb diluted >1:1,000; ++, detected at level similar to that of standard MAb diluted ≥1:100; or +++, detected at level greater than the lowest dilution of MAb standard. The order of the data is the same within each group. —, insufficient sample to perform the test.
Expressed as the median reciprocal (1/x) dilution yielding 75% neutralization. Values of ≤16 indicate that antibodies were detected but resulted in less than 75% neutralization at a 1:16 dilution.